Digicann Ventures Inc · CSE:DCNN.X

Digicann Ventures — Investor Presentation (September 2023)

11 slides from Digicann Ventures's investor presentation, September 2023

  1. Slide 1: Investor Presentation

    Investor Presentation September 2023 CSE:DCNN | OTC: AGFAF

  2. Slide 2: Forward-Looking Statements & Disclaimer

    Forward-Looking Statements & Disclaimer This presentation does not constitute an “offering memorandum” by Digicann Ventures Ltd. (“Digicann” or the “Company”) as such term is defined under Canadian securities legislation and confers no statutory, contractual or other similar rights of rescission or

  3. Slide 3: Digicann Ventures Ltd.

    Digicann Ventures Ltd. CSE: DCNN Digicann Ventures Ltd. (“Digicann” or the OTC: AGFAF “Company”) is a company focused on opportunities within the global cannabis industry. Digicann Ventures Ltd. is focused on In Germany, Digicann’s subsidiary, Farmako GmbH, is dedicated to becoming Europe’s opportun

  4. Slide 4: Farmako

    Farmako EUROPEAN DISTRIBUTION PERMITS & AGREEMENT LICENCES • Among the top players • Permit for Narcotic Drug in the German Handling (§3 BtmG) distribution market • Wholesale license for • Core focus on efficient distribution of medicinal Since the start of operations distribution, fast products (§

  5. Slide 5: Farmako

    | Farmako Farmako is fully licensed in Germany and in the UK wy K<S>_ Distribution network of over European patients 19,800 pharmacies in Germany, with better and more F A R M A KO well-established client base cannabis products. with lean company setup (7 FTE), professional team & Far beyond Healthc

  6. Slide 6: Farmako

    Farmako Digicann Ventures and Farmako are creating synergies in Germany and across Europe Already >10 companies in Germany hold distribution licences -> increased Farmako is fully licensed in Germany probability of additional applications being denied Together with Farmako, Digicann Ventures Farmako

  7. Slide 7: Our Leaders

    Our Leaders Nick Kuzyk Fiona Fitzmaurice Katrin Eckmans CEO & Director CFO & Director Managing Director & CEO, Farmako GmbH Mr. Kuzyk has more than 20 years of experience Ms. Fitzmaurice is a Chartered Professional in the areas of business development, corporate Accountant with over 14 years of expe

  8. Slide 8: Board of Directors – Independent Members

    Board of Directors – Independent Members Anthony Carnevale Jonathan Hirsh Independent Director Independent Director Anthony Carnevale is an established cannabis industry professional and Best known for his influential work as @Weedstagram416 on the Instagram entrepreneur. Mr. Carnevale began his car

  9. Slide 9: Recent Developments

    Recent Developments Agra Ventures Announces Details of Aug 2 Share Consolidation, Name Change, and Ticker Symbol Change Agra Ventures Announces Results of July 12 its Annual General & Special Meeting Amicably Exited Unprofitable Joint June 16 Venture Appointed Jonathan Hirsh to its Board June 7 of D

  10. Slide 10: Digicann Ventures Capitalization Table

    Digicann Ventures Investors Capitalization Table: Type Amount Common Shares (as at August 8, 2023) 6,531,786 Warrants (as at August 8, 2023) 91,388 Options (as at August 8, 2023) 24,504 RSUs (as at August 8, 2023) 88,852 Total 6,736,530 Common Shares Listed on Multiple Stock Exchanges: CSE: OTC: DCN

  11. Slide 11: Contact Info

    Contact Info Feel free to get in touch with For investor inquiries: us at your convenience. E: ir@digicann.io T: (800) 783-6056 Financial information and other filings are available on Digicann Ventures’ profile page on: https://sedar.com/ 11

Digicann Ventures — Investor Presentation (September 2023) on 6ix